Compare · ASLE vs STE
ASLE vs STE
Side-by-side comparison of AerSale Corporation (ASLE) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- ASLE operates in Consumer Discretionary, while STE operates in Health Care - the two are in different parts of the market.
- STE is the larger of the two at $20.78B, about 69.4x ASLE ($299.6M).
- Over the past year, ASLE is up 4.6% and STE is down 13.7% - ASLE leads by 18.3 points.
- STE has been more active in the news (39 items in the past 4 weeks vs 8 for ASLE).
- STE has more recent analyst coverage (16 ratings vs 5 for ASLE).
- Company
- AerSale Corporation
- STERIS plc (Ireland)
- Price
- $6.24-1.66%
- $209.09-1.72%
- Market cap
- $299.6M
- $20.78B
- 1M return
- -4.61%
- +3.66%
- 1Y return
- +4.63%
- -13.70%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2019
- News (4w)
- 8
- 39
- Recent ratings
- 5
- 16
AerSale Corporation
AerSale Corporation provides aftermarket commercial aircraft, engines, and its parts to passenger and cargo airlines, leasing companies, original equipment manufacturers, and government and defense contractors, as well as maintenance, repair, and overhaul (MRO) service providers worldwide. It operates in two segments, Asset Management Solutions and Technical Operations (TechOps). The Asset Management Solutions segment engages in the sale and lease of aircraft, engines, and airframes, as well as disassembly of these assets for component parts. The TechOps segment provides internal and third-party aviation services, including internally developed engineered solutions, heavy aircraft maintenance and modification, and component MRO, as well as storage and disassembly services. This segment also provides aircraft modifications, cargo/tanker conversions of aircraft, and aircraft storage; and MRO services for landing gear, thrust reversers, hydraulic systems, and other aircraft components. The company was founded in 2008 and is headquartered in Coral Gables, Florida.
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest ASLE
- Director Nichols Robert B. was granted 19,623 shares (SEC Form 4)
- Director Mullins Thomas Wiese was granted 19,623 shares, increasing direct ownership by 73% to 46,424 units (SEC Form 4)
- Director Mitchell Thomas Duncan was granted 19,623 shares, increasing direct ownership by 81% to 43,880 units (SEC Form 4)
- Director Levy Andrew C was granted 19,623 shares, increasing direct ownership by 32% to 80,528 units (SEC Form 4)
- Director Fedder Judith Ann was granted 19,623 shares, increasing direct ownership by 32% to 81,798 units (SEC Form 4)
- Director Dibattiste Carol was granted 19,623 shares, increasing direct ownership by 81% to 43,880 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by AerSale Corporation
- AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit
- SEC Form 10-Q filed by AerSale Corporation
- AerSale Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest STE
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam covered exercise/tax liability with 401 units of Ordinary Shares, decreasing direct ownership by 1% to 36,678 units (SEC Form 4)
- V.P. & Corporate Treasurer Tamaro Renato covered exercise/tax liability with 65 units of Ordinary Shares, decreasing direct ownership by 1% to 6,194 units (SEC Form 4)
- Sr. VP and GM, Life Sciences Madsen Julia covered exercise/tax liability with 195 units of Ordinary Shares, decreasing direct ownership by 2% to 12,257 units (SEC Form 4)
- SVP & GM, AST Kohler Kenneth E covered exercise/tax liability with 150 units of Ordinary Shares, decreasing direct ownership by 1% to 11,332 units (SEC Form 4)
- SVP & Chief HRO Fraser Mary Clare covered exercise/tax liability with 600 units of Ordinary Shares, decreasing direct ownership by 4% to 13,716 units (SEC Form 4)
- President and CEO Carestio Daniel A covered exercise/tax liability with 1,889 units of Ordinary Shares and sold $946,799 worth of Ordinary Shares (4,428 units at $213.82), decreasing direct ownership by 9% to 63,647 units (SEC Form 4)
- Sr. Vice Pres., CFO Burton Karen L covered exercise/tax liability with 90 units of Ordinary Shares, decreasing direct ownership by 0.68% to 13,184 units (SEC Form 4)
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam covered exercise/tax liability with 365 units of Ordinary Shares, decreasing direct ownership by 0.97% to 37,079 units (SEC Form 4)
- V.P. & Corporate Treasurer Tamaro Renato covered exercise/tax liability with 64 units of Ordinary Shares, decreasing direct ownership by 1% to 6,259 units (SEC Form 4)
- Sr. VP and GM, Life Sciences Madsen Julia covered exercise/tax liability with 239 units of Ordinary Shares, decreasing direct ownership by 2% to 12,452 units (SEC Form 4)